English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  51824740    ???header.onlineuser??? :  722
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"chuang wl"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 16-40 of 84  (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page

Institution Date Title Author
中山醫學大學 2021 Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan Cheng, PN; Mo, LR; Chen, CT; Chen, CY; Huang, CF; Kuo, HT; Lo, CC; Tseng, KC; Huang, YH; Tai, CM; Peng, CY; Bair, MJ; Chen, CH; Yeh, ML; Lin, CL; Lin, CY; Lee, PL; Chong, LW; Hung, CH; Chang, T; Huang, JF; Yang, CC; Hu, JT; Lin, CW; Wang, CC; Su, WW; Hsieh, TY; Lin, CL; Tsai, WL; Lee, TH; Chen, GY; Wang, SJ; Chang, CC; Yang, SS; Wu, WC; Huang, CS; Chou, KH; Kao, CN; Tsai, PC; Liu, CH; Lee, MH; Cheng, CY; Tsai, MC; Liu, CJ; Dai, CY; Lin, HC; Kao, JH; Chuang, WL; Yu, ML
中山醫學大學 2020 Executive summary of the DAROC clinical practice guidelines for diabetes care-2018 Diabetes Association of the Republic of China (Taiwan) Chen, JF; Chen, HS; Chu, CH; Chuang, LM; Ho, LT; Hung, YJ; Kuo, CH; Li, HY; Lin, CH; Lin, KD; Lin, SY; Sheen, YJ; Sheu, WHH; Shin, SJ; Tsai, ST; Te Tu, S; Bai, CH; Chang, YC; Chang, TJ; Chang, CH; Chang, CJ; Chao, CC; Chen, CC; Chen, YL; Chong, K; Chuang, WL; Guo, LY; Hsieh, MC; Hsu, CC; Huang, LC; Huang, CN; Huang, YY; Hung, CS; Hung, WW; Hwu, CM; Jeng, JS; Jiang, YD; Juang, JMJ; Juang, JH; Kuo, CS; Kuo, JF; Kwok, CF; Lai, YC; Lee, MY; Lee, YJ; Lee, IT; Lee, CN; Lee, YT; Lee, TI; Lee, CH; Lin, LY; Lin, SD; Lin, KY; Lin, HJ; Lin, CH; Liu, CE; Lo, FS; Lu, CH; Lu, KC; Ma, WY; Ou, HY; Pei, D; Su, CC; Su, SL; Tan, ECH; Tien, KJ; Tsai, LK; Tseng, CH; Wang, JS; Weng, SF; Wu, WC; Yang, MC; Yang, YS; Yang, CH; Yang, WS; Yeh, JT; Yu, NC; Yu, TY
臺大學術典藏 2018-09-10T06:55:38Z Downcoiler surface fault prediction for a hot strip steel mill Hsu, Yl.;Yen, Jy.;Chen, Ch.;Chuang, Wl.;Jia-Yush Yen;Hsu, Y.-L.;Yen, J.-Y.;Chen, C.-H.;Chuang, W.-L.;Hsu, Yl.;Yen, Jy.;Chen, Ch.;Chuang, Wl.;Jia-Yush Yen; Chuang, W.-L.; Chen, C.-H.; Yen, J.-Y.; Hsu, Y.-L.; JIA-YUSH YEN
國家衛生研究院 2017-01-04 The paradoxical effects of different Hepatitis C viral loads on host DNA damage and repair abilities Wang, SC;Lai, KR;Li, CY;Chiang, CS;Yu, GY;Sakamoto, N;Tu, WY;Hsieh, MH;Huang, JF;Chuang, WL;Dai, CY;Yu, ML
中國醫藥大學 2015-01 Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B was associated with unexpected high rate of peripheral neuropathy (Marcellin P)*;(Wursthorn K);(Wedemeyer H);(Chuang WL);(Lau G);(Avila C);彭成元(Cheng-Yuan Peng);(Gane E);(Lim SG);(Fainboim H);(Foster GR);(Safadi R);(Rizzetto M);(Manns M);(Bao W);(Naoumov N)
高雄醫學大學 2015 Chronic hepatitis C infection is associated with insulin resistance and lipid profiles 戴嘉言;葉明倫;黃釧峰;侯正修;謝明彥;黃志富;林怡伶;林子堯;陳信成;王良彥;張文宇;董宏達; Dai, CY;Yeh, ML;Huang, CF;Hou, CH;Hsieh, MY;Huang, JF;Lin, IL;Lin, ZY;Chen, SC;Wang, LY;Chuang, WL;Yu, ML;Tung HD, .
中國醫藥大學 2014-01 Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-na?ve Taiwanese patients with chronic hepatitis B (Chien RN);彭成元(Cheng-Yuan Peng);(Kao JH);(Hu TH);(Lin CC);(Hu CT);(Chen CY);(Hsieh TY);(Lin HC);(Chuang WL)*
高雄醫學大學 2014 Impact of chronic hepatitis B and hepatitis C on adverse hepatic fibrosis in hepatocellular carcinoma related to betel quid chewing.  鄭貞英;蔡孟峰;蔡蕙如;莊麗月;林子堯;謝明裕;陳信成;莊萬龍;王良彥;余明隆;戴嘉言;蔡榮發; Jeng, JE;Tsai, MF;Tsai, HR;Chuang, LY;Lin, ZY;Hsieh, MY;Chen, SC;Chuang, WL;Wang, LY;Yu, ML;Dai, CY;Tsai, JF
高雄醫學大學 2014 Abbott RealTime HBV Assay Is More Sensitive in Detection of Low Viral Load and Little Impacted by Drug Resistant Mutation in Chronic Hepatitis B Patients under Nucleot(s)ide Analogues Therapy.  葉明倫;黃釧峰;黃駿逸;劉淑芬;楊華齡;謝明彥;黃志富;戴嘉言;莊萬龍;余明隆; Yeh, ML;Huang, CF;Huang, CI;Liu, SF;Yang, HL;Hsieh, MY;Huang, JF;Dai, CY;Chuang, WL;Yu, ML
高雄醫學大學 2014 inosine triphosphate pyrophosphatase 基因變異與慢性C型肝炎2/3基因型治療復發危險  戴嘉言;莊萬龍;余明隆; Dai, CY;Chuang, WL;Yu, ML
高雄醫學大學 2014 A 24-Week Pegylated Interferon Alpha-2b Versus a 12-Week Pegylated Interferon Alpha-2b Alone or With Ribavirin for Patients With Acute Hepatitis C  戴嘉言;莊萬龍;余明隆; Dai, CY;Chuang, WL;ML*, Yu
國家衛生研究院 2013-12 ENSA expression correlates with attenuated tumor propagation in liver cancer Chen, YL;Kuo, MH;Lin, PY;Chuang, WL;Hsu, CC;Chu, PY;Lee, CH;Huang, THM;Leu, YW;Hsiao, SH
中國醫藥大學 2013-03 Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced HBeAg seroconversion (Yang HC);(Chen CL);(Shen YC);彭成元(Cheng-Yuan Peng);(Liu CJ);(Tseng TC);(Su TH);(Chuang WL);(Yu ML);(Dai CY);(Liu CH);(Chen PJ);(Chen DS);(Kao JH)*
高雄醫學大學 2013 Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin.  GR*, Foster;Zeuzem, S;Pianko, S;Sarin, SK;Piratvisuth, T;Shah, S;Andreone, P;Sood, A;莊萬龍;Lee, CM;George, J;Gould, M;Flisiak, R;Jacobson, IM;Komolmit, P;Thongsawat, S;Tanwandee, T;Rasenack, J;Sola, R;Messina, I;Yin, Y;Cammarata, S;Feutren, G;Brown, KK. ; Foster, GR;Zeuzem, S;Pianko, S;Sarin, SK;Piratvisuth, T;Shah, S;Andreone, P;Sood, A;Chuang, WL;Lee, CM;George, J;Gould, M;Flisiak, R;Jacobson, IM;Komolmit, P;Thongsawat, S;Tanwandee, T;Rasenack, J;Sola, R;Messina, I;Yin, Y;Cammarata, S;Feutren, G;Brown, KK. 
高雄醫學大學 2012 Waist circumference; body mass index; serum uric acid; blood sugar; and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese population.  謝孟軒;林文一;潛詡涵;簡麗合;黃兆寬;楊正福;張寧家;黃釧峰;王肈齡;莊萬龍;余明隆;戴嘉言;何啟功 ; Hsieh, MH;Lin, WY;Chien, HH;Chien, LH;Huang, CK;Yang, JF;Chang, NC;Huang, CF;Wang, CL;Chuang, WL;Yu, ML;Dai, CY;Ho, CK
高雄醫學大學 2011 Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection.  黃志富;黃釧峰;余明隆;戴嘉言;黃駿逸;葉明倫;謝明裕;楊正福;謝明彥;林子堯;陳信成;莊萬龍 ; Huang JF;Huang CF;Yu ML;Dai CY;Huang CI;Yeh ML;Hsieh MH;Yang JF;Hsieh MY;Lin ZY;Chen SC;Chuang WL 
高雄醫學大學 2011 老年人C型肝炎  黃釧鋒;莊萬龍;余明隆 ; Huang CF;Chuang WL;Yu ML. 
高雄醫學大學 2011 Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients.  莊萬龍; Patel K;Thompson AJ;Chuang WL;Lee CM;Peng CY;Shanmuganathan G;Thongsawat S;Tanwandee T;Mahachai V;Pramoolsinsap C;Cho M;Han KH;Shah SR;Foster GR;Clark PJ;Pulkstenis E;Subramanian GM;McHutchison JG. 
高雄醫學大學 2011 Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups.  楊正福;林雅雲;謝孟軒;蔡秋鴻;劉淑芬;余明隆;戴嘉言;黃志富;林文一;林子堯;陳信成;莊萬龍 ; Yang JF;Lin YY;Hsieh MH;Tsai CH;Liu SF;Yu ML;Dai CY;Huang JF;Lin WY;Lin ZY;Chen SC;Chuang WL. 
高雄醫學大學 2010 C型肝炎病毒基因型第2/3型病毒病患以長效干擾素/雷巴威林縮短療程合併治療:雷巴威林起始劑量之重要角色  戴嘉言;黃釧峰;黃志富;莊萬龍;余明隆 ; Dai CY;Huang CF;Huang JF;Chuang WL;Yu ML 
高雄醫學大學 2010 Insulin resistance predicts rapid virological response in non-diabetic; non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: Some issues.  吳冠達;楊正福;莊萬龍;余明隆 ; Wu KT;Yang JF;Chuang WL;Yu ML 
高雄醫學大學 2009 Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms; substance use habits; and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma.  鄭貞英;蔡蕙如;莊麗月;蔡榮發;林子堯;謝明裕;陳信成;莊萬龍;王良彥;余明隆;戴嘉言;張建國 ; Jeng JE;Tsai HR;Chuang LY;Tsai JF;Lin ZY;Hsieh MY;Chen SC;Chuang WL;Wang LY;Yu ML;Dai CY;Chang JG. 
高雄醫學大學 2009 ribavirin早期劑量與C型肝炎病毒基因型第一型病毒合併治療反應之角色  戴嘉言;黃釧峰;莊萬龍;黃志富;余明隆 ; Dai CY;Huang CF;Chuang WL;Huang JF;Yu ML 
高雄醫學大學 2009 雷巴威林起始劑量與C型肝炎病毒基因型第1b亞型病毒以長效干擾素/雷巴威林合併治療反應之重要角色  戴嘉言;黃釧峰;莊萬龍;黃志富;余明隆 ; Dai CY;Huang CF;Chuang WL;Huang JF;Yu ML 
高雄醫學大學 2009 Treatment of chronic hepatitis C in Asia: when East meets West.  余明隆;莊萬龍 ; Yu ML;Chuang WL 

Showing items 16-40 of 84  (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page